These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35596627)

  • 21. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
    Vardhan S; Sahoo SK
    Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method.
    Jalalvand A; Khatouni SB; Najafi ZB; Fatahinia F; Ismailzadeh N; Farahmand B
    J Basic Clin Physiol Pharmacol; 2021 Jul; 33(1):85-95. PubMed ID: 34265888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
    Verma AK; Aggarwal R
    Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
    Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Doharey PK; Singh V; Gedda MR; Sahoo AK; Varadwaj PK; Sharma B
    J Biomol Struct Dyn; 2022 Aug; 40(12):5588-5605. PubMed ID: 33475021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Silico Molecular Dynamics of Griseofulvin and Its Derivatives Revealed Potential Therapeutic Applications for COVID-19.
    Aris P; Mohamadzadeh M; Wei Y; Xia X
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD.
    Meng JR; Liu J; Fu L; Shu T; Yang L; Zhang X; Jiang ZH; Bai LP
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation.
    Hossain R; Sarkar C; Hassan SMH; Khan RA; Arman M; Ray P; Islam MT; Daştan SD; Sharifi-Rad J; Almarhoon ZM; Martorell M; Setzer WN; Calina D
    Chin J Integr Med; 2022 Mar; 28(3):249-256. PubMed ID: 34913151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virtual screening of quinoline derived library for SARS-COV-2 targeting viral entry and replication.
    Anju A; Chaturvedi S; Chaudhary V; Pant P; Hussain F; Mishra AK
    J Biomol Struct Dyn; 2022 Nov; 40(18):8464-8493. PubMed ID: 34032180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review.
    Agrawal N; Goyal A
    Curr Pharm Biotechnol; 2022; 23(3):396-419. PubMed ID: 33882805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug.
    Ameen F; Mamidala E; Davella R; Vallala S
    J Infect Public Health; 2021 Oct; 14(10):1454-1460. PubMed ID: 34326009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds.
    Khanal P; Patil VS; Bhandare VV; Dwivedi PSR; Shastry CS; Patil BM; Gurav SS; Harish DR; Roy S
    Comput Biol Med; 2022 Jul; 146():105668. PubMed ID: 35667894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of in silico experimental model in the assessment of ciprofloxacin and levofloxacin interaction with main SARS-CoV-2 targets: S-, E- and TMPRSS2 proteins, RNA-dependent RNA polymerase and papain-like protease (PLpro)-preliminary molecular docking analysis.
    Marciniec K; Beberok A; Boryczka S; Wrześniok D
    Pharmacol Rep; 2021 Dec; 73(6):1765-1780. PubMed ID: 34052981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulants as Potential SARS-CoV-2 M
    Abo Elmaaty A; Eldehna WM; Khattab M; Kutkat O; Alnajjar R; El-Taweel AN; Al-Rashood ST; Abourehab MAS; Binjubair FA; Saleh MA; Belal A; Al-Karmalawy AA
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
    Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 M
    Bharadwaj S; Azhar EI; Kamal MA; Bajrai LH; Dubey A; Jha K; Yadava U; Kang SG; Dwivedi VD
    J Biomol Struct Dyn; 2022 Apr; 40(6):2769-2784. PubMed ID: 33150855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.
    Sonousi A; Mahran HA; Ibrahim IM; Ibrahim MN; Elfiky AA; Elshemey WM
    Pharmacol Rep; 2021 Dec; 73(6):1754-1764. PubMed ID: 34165771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2.
    Vijayakumar BG; Ramesh D; Joji A; Jayachandra Prakasan J; Kannan T
    Eur J Pharmacol; 2020 Nov; 886():173448. PubMed ID: 32768503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.